Literature DB >> 11577003

Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts.

D S Min1, T K Kwon, W S Park, J S Chang, S K Park, B H Ahn, Z Y Ryoo, Y H Lee, Y S Lee, D J Rhie, S H Yoon, S J Hahn, M S Kim, Y H Jo.   

Abstract

Phospholipase D (PLD) has been suggested to play an important role in a variety of cellular functions. PLD activity has been shown to be significantly elevated in many tumours and transformed cells, suggesting the possibility that PLD might be involved in tumorigenesis. In this study, we have established stable cell lines overexpressing PLD1 and PLD2 from fibroblast cells. These cells, but not control cells, showed altered growth properties and anchorage-independent growth in soft agar. Both PLD1 and PLD2 also induced an up-regulation of the activity of matrix metalloprotease-9 as detected by zymograms. Furthermore, both PLD1 and PLD2 transformants, but not vector-transfectants, induced undifferentiated sarcoma when transplanted into nude mice. Both PLD1- and PLD2-mediated cell cycle distributions in stable cell lines revealed an increased fraction of cells in the S phase compared with control cells. Interestingly, the level of cyclin D3 protein, known as an activator of G(1) to S phase transition in the cell cycle, was aberrantly high in cells overexpressing PLD1 and PLD2 compared with control cells. These results suggest that overexpression of PLD isozymes may play an important role in neoplastic transformation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11577003     DOI: 10.1093/carcin/22.10.1641

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  34 in total

1.  The molecular basis of phospholipase D2-induced chemotaxis: elucidation of differential pathways in macrophages and fibroblasts.

Authors:  Katie Knapek; Kathleen Frondorf; Jennalee Post; Stephen Short; Dianne Cox; Julian Gomez-Cambronero
Journal:  Mol Cell Biol       Date:  2010-07-20       Impact factor: 4.272

2.  A comprehensive model that explains the regulation of phospholipase D2 activity by phosphorylation-dephosphorylation.

Authors:  Karen M Henkels; Hong-Juan Peng; Kathleen Frondorf; Julian Gomez-Cambronero
Journal:  Mol Cell Biol       Date:  2010-02-22       Impact factor: 4.272

Review 3.  Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.

Authors:  David A Foster
Journal:  Biochim Biophys Acta       Date:  2009-03-02

4.  Rebamipide-induced downregulation of phospholipase D inhibits inflammation and proliferation in gastric cancer cells.

Authors:  Dong Woo Kang; Gyesik Min; Do Yoon Park; Ki Whan Hong; Do Sik Min
Journal:  Exp Mol Med       Date:  2010-08-31       Impact factor: 8.718

5.  Serum deprivation confers the MDA-MB-231 breast cancer line with an EGFR/JAK3/PLD2 system that maximizes cancer cell invasion.

Authors:  Qing Ye; Samuel Kantonen; Julian Gomez-Cambronero
Journal:  J Mol Biol       Date:  2012-12-10       Impact factor: 5.469

6.  Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.

Authors:  Mayur Gadiya; Noriko Mori; Maria D Cao; Yelena Mironchik; Samata Kakkad; Ingrid S Gribbestad; Kristine Glunde; Balaji Krishnamachary; Zaver M Bhujwalla
Journal:  Cancer Biol Ther       Date:  2014-02-20       Impact factor: 4.742

7.  Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity.

Authors:  Robert Lavieri; Sarah A Scott; Jana A Lewis; Paige E Selvy; Michelle D Armstrong; H Alex Brown; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2009-03-06       Impact factor: 2.823

Review 8.  Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis.

Authors:  Wenjuan Su; Qin Chen; Michael A Frohman
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

9.  Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.

Authors:  Dong Woo Kang; Do Sik Min
Journal:  PLoS One       Date:  2010-08-12       Impact factor: 3.240

10.  Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53.

Authors:  Li Hui; Tarek Abbas; Rafal M Pielak; Troy Joseph; Jill Bargonetti; David A Foster
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.